Gao Haoran, Kosins Allison E, Cook-Mills Joan M
Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Immunol Rev. 2024 Sep;326(1):151-161. doi: 10.1111/imr.13367. Epub 2024 Jul 15.
Food allergy can be life-threatening and often develops early in life. In infants and children, loss-of-function mutations in skin barrier genes associate with food allergy. In a mouse model with skin barrier mutations (Flakey Tail, FT+/- mice), topical epicutaneous sensitization to a food allergen peanut extract (PNE), an environmental allergen Alternaria alternata (Alt) and a detergent induce food allergy and then an oral PNE-challenge induces anaphylaxis. Exposures to these allergens and detergents can occur for infants and children in a household setting. From the clinical and preclinical studies of neonates and children with skin barrier mutations, early oral exposure to allergenic foods before skin sensitization may induce tolerance to food allergens and thus protect against development of food allergy. In the FT+/- mice, oral food allergen prior to skin sensitization induce tolerance to food allergens. However, when the skin of FT+/- pups are exposed to a ubiquitous environmental allergen at the time of oral consumption of food allergens, this blocks the induction of tolerance to the food allergen and the mice can then be skin sensitized with the food allergen. The development of food allergy in neonatal FT+/- mice is mediated by altered skin responses to allergens with increases in skin expression of interleukin 33, oncostatin M and amphiregulin. The development of neonate food allergy is enhanced when born to an allergic mother, but it is inhibited by maternal supplementation with α-tocopherol. Moreover, preclinical studies suggest that food allergen skin sensitization can occur before manifestation of clinical features of atopic dermatitis. Thus, these parameters may impact design of clinical studies for food allergy, when stratifying individuals by loss of skin barrier function or maternal atopy before offspring development of atopic dermatitis.
食物过敏可能危及生命,且通常在生命早期就会出现。在婴儿和儿童中,皮肤屏障基因的功能丧失突变与食物过敏有关。在一种具有皮肤屏障突变的小鼠模型(片状尾巴,FT+/-小鼠)中,对食物过敏原花生提取物(PNE)、环境过敏原链格孢(Alt)和一种洗涤剂进行局部表皮致敏会引发食物过敏,随后口服PNE激发会引发过敏反应。婴儿和儿童在家庭环境中可能接触到这些过敏原和洗涤剂。从对患有皮肤屏障突变的新生儿和儿童的临床及临床前研究来看,在皮肤致敏之前早期口服致敏性食物可能会诱导对食物过敏原的耐受性,从而预防食物过敏的发生。在FT+/-小鼠中,在皮肤致敏之前口服食物过敏原可诱导对食物过敏原的耐受性。然而,当FT+/-幼崽在口服食物过敏原时其皮肤接触到一种普遍存在的环境过敏原,这会阻断对食物过敏原耐受性的诱导,然后这些小鼠就会被食物过敏原进行皮肤致敏。新生FT+/-小鼠食物过敏的发生是由皮肤对过敏原反应的改变介导的,白细胞介素33、抑瘤素M和双调蛋白的皮肤表达增加。当出生于过敏母亲时,新生儿食物过敏的发生会增强,但母体补充α-生育酚可抑制这种情况。此外,临床前研究表明,食物过敏原皮肤致敏可能在特应性皮炎临床特征出现之前就已发生。因此,在根据皮肤屏障功能丧失或母体特应性对患有特应性皮炎的后代进行分层时,这些参数可能会影响食物过敏临床研究的设计。